Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.

Saved in:
Bibliographic Details
Title: Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.
Authors: Burcher, Kimberly M.1 (AUTHOR) kburcher@wakehealth.edu, Lantz, Jeffrey W.1 (AUTHOR) jwlantz@wakehealth.edu, Gavrila, Elena1 (AUTHOR) egavrila@wakehealth.edu, Abreu, Arianne2 (AUTHOR) a_abreu0419@email.campbell.edu, Burcher, Jack T.3 (AUTHOR) jburcher83447@med.lecom.edu, Faucheux, Andrew T.1 (AUTHOR) afaucheu@wakehealth.edu, Xie, Amy1 (AUTHOR) axie@wakehealth.edu, Jackson, Clayton1 (AUTHOR) cwjackso@wakehealth.edu, Song, Alexander H.1 (AUTHOR) asong@wakehealth.edu, Hughes, Ryan T.1 (AUTHOR) ryhughes@wakehealth.edu, Lycan Jr., Thomas1 (AUTHOR) tlycan@wakehealth.edu, Bunch, Paul M.1 (AUTHOR) pbunch@wakehealth.edu, Furdui, Cristina M.1 (AUTHOR) cfurdui@wakehealth.edu, Topaloglu, Umit1 (AUTHOR) Umit.Topaloglu@wakehealth.edu, D'Agostino Jr., Ralph B.1 (AUTHOR) rdagosti@wakehealth.edu, Zhang, Wei1 (AUTHOR) wezhang@wakehealth.edu, Porosnicu, Mercedes1 (AUTHOR) mporosni@wakehealth.edu
Source: Cancers. Nov2021, Vol. 13 Issue 22, p5733. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers13225733